Global Biosimilars Market 2014-2018: New research report at SandlerResearch.org.

Call at +1 888 391 5441 to purachse this report OR send an email on sales@sandlerresearch.org with your contact details. Global Biosimilars Market to grow at a CAGR of 27.58 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing number of patent expirations. The Global Biosimilars Market has also been witnessing the outsourcing of biosimilar manufacturing. However, the risks related to drug failure could pose a challenge to the growth of this market. Complete report of 106 Pages is available @ http://www.sandlerresearch.org/global-biosimilars-market-2014-2018.html. Global Biosimilars Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, EMEA and APAC regions; it also covers the Global Biosimilars market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors dominating this space include Biocon Ltd., Hospira Inc., Mylan Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Dr. Reddys Laboratories Ltd., F. Hoffmann-La Roche Ltd., 3SBio Inc., and Celltrion Inc. Other vendors mentioned in the report are Actavis plc, Amgen Inc., AstraZeneca plc, Baxter International Inc., Biogen Idec Inc., Bioton S.A., Boehringer Ingelheim GmbH, Cipla Ltd., Coherus Biosciences Inc., Daiichi Sankyo Co. Ltd., Emcure Pharmaceuticals Ltd., GE Healthcare Ltd., GeneScience Pharmaceuticals Co. Ltd., GlaxoSmithKline plc, JCR Pharmaceuticals Co. Ltd., iBio Inc., LG Life Sciences Co. Ltd., Merck & Co. Inc., Pfizer Inc., Ranbaxy Laboratories Ltd., Samsung Biologics Co. Ltd., Sanofi S.A., and Wockhardt Ltd. Key questions answered in this report: What will the market size be in 2018 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?

Inquiry Before Buying on this Report @ http://www.sandlerresearch.org/inquirebefore-buying?rname=14863 Global Biosimilars Market 2014-2018

Table Of Contents 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Application 08. Geographical Segmentation 09. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Trends and their Impact 16. Vendor Landscape 17. Patent Expiries 18. Key Vendor Analysis 18.1 Biocon Ltd. 18.2 Celltrion Inc. 18.3 Dr. Reddy's Laboratories Ltd. 18.6 Intas Pharmaceuticals Ltd.

18.4 F. Hoffmann-La Roche Ltd. 18.7 Mylan Inc. 18.10 3SBio Inc.

18.5 Hospira Inc.

18.8 Novartis AG 18.9 Teva Pharmaceutical Industries Ltd.

19. Other Reports in this Series Global Biosimilars Market 2014-2018

Inquire for Discount @ http://www.sandlerresearch.org/discount?rname=14863 List of Exhibits: Exhibit 1: Market Research Methodology Exhibit 2: Global Biosimilars Market 2013-2018 (US$ million) Exhibit 3: Biosimilars Market in the US 2013-2018 (US$ million) Exhibit 4: Biosimilars Market in Europe 2013-2018 (US$ million) Exhibit 5: Biosimilars Market in Japan 2013-2018 (US$ million) Exhibit 6: Biosimilars Market in India 2013-2018 (US$ million) Exhibit 7: Biosimilars Market in China 2013-2018 (US$ million) Exhibit 8: Global Biosimilars Market Segmentation by Application Exhibit 9: Global Biosimilars Market by Geographical Segmentation 2013 Exhibit 10: Biosimilars Market in the APAC Region 2013-2018 (US$ million) Exhibit 11: Biosimilars Market in the EMEA Region 2013-2018 (US$ million) Exhibit 12: Biosimilars Market in the Americas 2013-2018 (US$ million) Exhibit 13: Global Biosimilars Market by Geographical Segmentation (US$ million) Exhibit 14: Global Biosimilars Market by Geographical Segmentation Exhibit 15: Comparison of YOY Growth Rates among various Geographies in the Global Biosimilars Market Exhibit 16: Business Segmentation of Biocon Ltd. Exhibit 17: Business Segmentation of Dr. Reddy's Laboratories Ltd. Exhibit 18: Business Segmentation of F. Hoffmann-La Roche Ltd. Exhibit 19: Business Segmentation of Hospira Inc. Exhibit 20: Business Segmentation of Mylan Inc. Exhibit 21: Business Segmentation of Novartis AG Exhibit 22: Business Segmentation of Teva Pharmaceutical Industries Ltd.

Buy a copy of report http://www.sandlerresearch.org/purchase?rname=14863 Browse more report on Pharmaceutical Contact sales@sandlerresearch.org / Call +1 888 391 5441 for further information on Global Biosimilars Market 2014-2018 report OR for any other market research and intelligence needs you may have for your business.

Global Biosimilars Market 2014-2018